Gerda Elisabeth Villadsen

The Danish comorbidity in liver transplant recipients study (DACOLT): a non-interventional prospective observational cohort study

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Magda Teresa Thomsen, University of Copenhagen
  • ,
  • Julie Høgh, University of Copenhagen
  • ,
  • Andreas Dehlbæk Knudsen, University of Copenhagen
  • ,
  • Anne Marie Reimer Jensen, University of Copenhagen
  • ,
  • Marco Gelpi, University of Copenhagen
  • ,
  • Gerda E. Villadsen
  • Rozeta Abazi, University of Southern Denmark
  • ,
  • Peter Holland-Fischer, Aalborg University
  • ,
  • Lars Køber, University of Copenhagen
  • ,
  • Otto Clemmesen, University of Copenhagen
  • ,
  • Paul Suno Krohn, University of Copenhagen
  • ,
  • Jens Hillingsø, University of Copenhagen
  • ,
  • Tina Vilsbøll, Gentofte Hospital
  • ,
  • Tor Biering-Sørensen, University of Copenhagen
  • ,
  • Klaus Fuglsang Kofoed, Aalborg University
  • ,
  • Børge Grønne Nordestgaard, University of Copenhagen
  • ,
  • Allan Rasmussen, University of Copenhagen
  • ,
  • Susanne Dam Nielsen, University of Copenhagen

Background: Liver transplantation is the only curative treatment for patients with end-stage liver disease. Short-term survival has improved due to improved surgical techniques and greater efficacy of immunosuppressive drugs. However, long-term survival has not improved to the same extent as the short-term survival, and the 10-year survival after liver transplantation is 60%. In addition to liver- and transplant-related causes, comorbidities such as cardiovascular, pulmonary, renal, and metabolic diseases have emerged as leading causes of morbidity and mortality in liver transplant recipients. The objective of this study is to assess the burden of comorbidities and identify both liver- and transplant-related risk factors as well as traditional risk factors that contribute to the pathogenesis of comorbidity in liver transplant recipients. Methods/design: The Danish Comorbidity in Liver Transplant Recipients (DACOLT) study is an observational, longitudinal study. We aim to include all adult liver transplant recipients in Denmark (n = approx. 600). Participants will be matched by sex and age to controls from the Copenhagen General Population Study (CGPS) and the Copenhagen City Heart Study (CCHS). Physical and biological measures including blood pressure, ankle–brachial index, spirometry, exhaled nitric oxide, electrocardiogram, transthoracic echocardiography, computed tomography (CT) angiography of the heart, unenhanced CT of chest and abdomen and blood samples will be collected using uniform protocols in participants in DACOLT, CGPS, and CCHS. Blood samples will be collected and stored in a research biobank. Follow-up examinations at regular intervals up to 10 years of follow-up are planned. Discussion: There is no international consensus standard for optimal clinical care or monitoring of liver transplant recipients. This study will determine prevalence, incidence and risk factors for comorbidity in liver transplant recipients and may be used to provide evidence for guidelines on management, treatment and screening and thereby contribute to improvement of the long-term survival. Trial registration ClinicalTrials.gov: NCT04777032; date of registration: March 02, 2021.

Original languageEnglish
Article number145
JournalBMC Gastroenterology
Volume21
Issue1
Number of pages9
ISSN1471-230X
DOIs
Publication statusPublished - 2021

Bibliographical note

Publisher Copyright:
© 2021, The Author(s).

Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.

    Research areas

  • Cardiovascular diseases, Comorbidity, Liver transplantation, Metabolic diseases, Renal diseases, Respiratory diseases

See relations at Aarhus University Citationformats

ID: 218478360